MRTNZ

MRTNZ Investment Office · The 360 Vantage

HIMS · NYSE

Hims & Hers Health, Inc. Class A

Health Care · Medical/Nursing Services

Reference price$29.33As of Jul 28, 2026
Market capitalization$6.79B
52-week range$13.74–$70.43
Coverage statuscomplete
Data qualitycomplete

Street view

Analyst targets

Published sell-side aggregation—not an MRTNZ forecast.

Low$21.00-28.4% vs. reference
Average$30.46+3.9% vs. reference
High$40.00+36.4% vs. reference
4 Buy8 Hold0 Sell

Forward calendar

Current earnings expectations

Consensus may change until the company reports.

Expected reportAug 10, 2026Jun 2026
Consensus EPS-$0.073 estimates
Expected range-$0.16–-$0.01Low to high EPS
Dec 2026$0.03Street EPS consensus
Dec 2027$0.52Street EPS consensus
Dec 2028$0.79Street EPS consensus

Reported results

Annual financial snapshot

Fiscal period ended Dec 31, 2025.

MetricCurrentPrior
Revenue+59.0% YoY$2.35B$1.48B
Operating income$0.11B$0.06B
Net income$0.13B$0.13B
Operating cash flow$0.3B$0.25B
Capital expenditures($0.23B)($0.04B)

Current context

Related news

Company-linked articles surfaced by Nasdaq.

BNK Invest

Noteworthy Friday Option Activity: IMAX, GEV, HIMS

BNK Invest

Principal US Small-Cap ETF Experiences Big Inflow

The Motley Fool

Hims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026?

Evidence

Sources & method

Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →

Facts, estimates, and scenario analysis are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Eligibility, consensus, and price data can change. This page is illustrative research, not investment advice.